RAM Releasing, the new midnight label from Film Movement, has acquired U.S. rights to controversial castration movie "Moebius.
TOKYO — The Tokyo International Film Festival today unveiled the line-up for its 26th edition, which will unspool Oct. 17-25 in Tokyo's Roppongi Hills entertainment and shopping complex. The…
Kim Ki-duk's latest is a gloriously off-the-charts study in perversity featuring castration, rape and incest.
Getting to the Lido was easy for South Korean director Kim Ki-duk, who presents his "Moebius" in the Venice festival's out of competition section Tuesday. Getting his picture a release at home was…
The documentary "A Fuller Life," which screens here Sunday and Tuesday, includes never-seen footage that ranges from World War II-ravaged families to scenes from a long-ago Venice Film Festival. In…
New York based-digital distributor FilmBuff will digitally release docu "Double Play: James Benning and Richard Linklater," which world preems Thursday in Venice Classics, and also handle worldwide…
HONG KONG — South Korean auteur Kim Ki-duk has won his battle to have his new film "Moebius" released in Korean theaters, but only after a third appeal to the country's censors and three minutes of…
South Korean film-maker Kim Ki-duk finds his latest film invited to Venice, but banned at home. Now the iconoclastic auteur is mounting a PR campaign in favor of a local release.
"Gravity," "Under the Skin" and "Moebius" are among our critic's most hotly anticipated titles at this year's Venice Film Festival.
While not quite a "Notorious" F.L.O.P., French spy thriller and Hitchcock wannabe "Mobius" struggles to suggest why its central pair of lovers would want to be together beyond physical compatibility…
Domestic Film DAILY
PROVIDED BY: Box Office
Guardians of the Galaxy
Guardians of the Galaxy1Daily:$1.6M Cumulative:$258.3M Disney 3.68%
Teenage Mutant Ninja Turtles
Teenage Mutant Ninja Turtles2Daily:$1.1M Cumulative:$150.7M Paramount Pictures -0.62%
If I Stay
If I Stay3Daily:$1.0M Cumulative:$20.6M Warner Brothers / New Line -0.71%